Abpro Alternatives & Competitors
12 companies similar to Abpro — Developing antibody therapies to improve the lives of patients facing severe and...
Companies similar to Abpro
Merus N.V.
Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community...
Utrecht, The Netherlands
RemedyBio
Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of imm...
Dublin, Ireland
Inhibrx Biosciences, Inc.
Innovation Focused Outcomes Driven
San Diego, United States
FK Biotecnologia
Pioneering biomedical innovation with advanced biotech solutions since 1999.
Track all Abpro competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
MacroGenics, Inc.
Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious disea...
Rockville, United States
BiosPacific
Manufacturer and supplier of antibodies and antigens of exceptional quality, to the IVD ma...
Emeryville, United States
AMSBIO
AMSBIO is a global supplier of research products and custom services for biological and ph...
Abingdon, United Kingdom
Ichor Biologics
Accelerating cures for infectious diseases
New York, United States
Biotheus Inc.
To Inspire Each Other and Create Effective Medicines for Humankind
Zhuhai, China
-logo.jpg "Protein Alternatives SL (PROALT)"){kind=logo}
Protein Alternatives SL (PROALT)
Proteins and antibodies applied to health
Tres Cantos, Spain
Y-Biologics
Exploring antibodies, creating novel therapeutics
Daejeon, Korea South
About Abpro
Abpro is a biotech company that is dedicated to advancing antibody therapeutics for severe diseases. With a focus on immuno-oncology and ophthalmology, the company leverages its proprietary DiversImmune® and MultiMab platforms to develop next-gen antibodies. Collaborating with global pharmaceutical and research partner...
Antibody Therapeutics, Immuno-Oncology, Ophthalmology, Reagents, Biochemistry, Recombinant Proteins, Collaborations, Therapeutic Antibodies, Cancer Research, Infectious Diseases, T-Cell Engagers, Wet AMD, DME, Bi-Specific Antibodies
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Abpro and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Abpro on 13 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
